Category: Portfolio News

Trellis Bioscience raises $9 million to advance clinical development of calpurbatug (TRL1068)

Trellis Bioscience raises $9 million to advance clinical development of calpurbatug (TRL1068)

Trellis Bioscience, a clinical-stage biotechnology company developing native human monoclonal antibodies (mAbs) to treat intractable infectious diseases, has announced the closing of a $9 million Series C financing. This funding will support completion of the Company's Phase 2 trial of calpurbatug (TRL1068), an investigational mAb treatment for chronic prosthetic joint

Read More
Paragraf growth designs accelerated with addition of industry heavyweights to Advisory Committee and Board of Directors

Paragraf growth designs accelerated with addition of industry heavyweights to Advisory Committee and Board of Directors

Paragraf, the Huntingdon based global leader in the commercialisation of graphene-based electronics, has announced the formation of a new Advisory Committee that will include industry masters Oreste Donzella, Jean-Michel Richard and Thomas Piliszczuk. Donzella and Richard will also join Paragraf’s Board as Non-Executive Directors. The commercially focused Advisory Committee has

Read More
NASA awards PlanetiQ contract to expand access to Commercial Polarimetric GNSS Radio Occultation Satellite Data

NASA awards PlanetiQ contract to expand access to Commercial Polarimetric GNSS Radio Occultation Satellite Data

PlanetiQ has announced that NASA has awarded the company an expanded contract through NASA's Commercial Smallsat Data Acquisition (CSDA) program, broadening access to commercial satellite data for the scientific community. This contract expands PlanetiQ's CSDA portfolio to add high-SNR GNSS polarimetric radio-occultation data to PlanetiQ's existing NASA CSDA offerings of

Read More
Antevia Networks secures JOSCAR Accreditation as qualified supplier to aerospace, defence and security sectors

Antevia Networks secures JOSCAR Accreditation as qualified supplier to aerospace, defence and security sectors

Antevia Networks, the telecoms equipment vendor changing the economics of 5G private networks, today announced that it has successfully achieved accreditation for JOSCAR (the Joint Supply Chain Accreditation Register), a collaborative tool used by a growing number of prime contractors and buyers in the aerospace, defence and security industry to

Read More
PlanetiQ advances atmospheric intelligence through high-performance GNSS-RO technology

PlanetiQ advances atmospheric intelligence through high-performance GNSS-RO technology

PlanetiQ s advancing global atmospheric monitoring and weather intelligence through the Global Navigation Satellite System Radio Occultation (GNSS-RO) technology, a space-based remote sensing capability designed to deliver highly accurate atmospheric measurements for weather forecasting, climate science and space weather applications. By combining advanced radio occultation sensors with a low Earth

Read More
Paragraf introduces PMF2000 GFET

Paragraf introduces PMF2000 GFET

Paragraf, the Cambridgeshire-based global leader in the commercialisation of graphene-based electronics, is expanding its Graphene Field Effect Transistor (GFET) product line with the introduction of PMF2000 GFET. The company is continuing growth of its product portfolio with the release of the PMF2000 GFET, another pristine, contamination-free layer graphene device. This

Read More
Zeotap named High Performer in G2 Grid® for Enterprise CDPs (2026)

Zeotap named High Performer in G2 Grid® for Enterprise CDPs (2026)

At Zeotap, the mission has always been simple: help enterprises unlock the full value of their customer data and they are proud to share that they’ve been recognised as a High Performer in the G2 Grid® for Enterprise Customer Data Platforms (CDP), based entirely on verified feedback from enterprise users.

Read More
Paragraf and Archer Materials announce strategic collaboration on graphene‑based quantum devices

Paragraf and Archer Materials announce strategic collaboration on graphene‑based quantum devices

Paragraf, a leader in graphene electronics and fabrication, and Archer Materials Ltd., a technology company specializing in advanced materials and quantum‑enabling devices, has announced a cooperative research and development program focused on next‑generation quantum computing hardware enabled by graphene‑based device platforms. The collaboration brings together Paragraf’s commercially scalable graphene platform

Read More
PlanetiQ awarded $15M U.S. Air Force STRATFI contract to advance next-generation weather data from space

PlanetiQ awarded $15M U.S. Air Force STRATFI contract to advance next-generation weather data from space

PlanetiQ has announced it has been awarded a $15 million, 48-month Strategic Funding Increase (STRATFI) contract by the U.S. Air Force. The program will support the development and launch of spacecraft equipped with next-generation Global Navigation Satellite System (GNSS) RO, R and PRO instruments and the delivery of high-value weather

Read More
Glydways raises oversubscribed $170M Series C as first autonomous vehicle networks enter public operation in 2026

Glydways raises oversubscribed $170M Series C as first autonomous vehicle networks enter public operation in 2026

Glydways, the company delivering a new category of urban mobility, has announced its $170 million Series C fundraise. The round was co-led by Suzuki Motor Corporation, ACS Group, and Khosla Ventures with additional participation from existing investors Mitsui Chemicals and Gates Frontier, and new investor, Obayashi Corporation, a leading general

Read More
Resolve Therapeutics and Institut Pasteur collaborate to identify Cell-Free RNA triggers in autoimmunity

Resolve Therapeutics and Institut Pasteur collaborate to identify Cell-Free RNA triggers in autoimmunity

Resolve Therapeutics, a next-generation biopharma company transforming the treatment of autoimmune diseases with innovative non-immunosuppressive drugs (resolvetherapeutics.com) and the Institut Pasteur de Montevideo, the premier basic science laboratory at the forefront of cfRNA in human disease (pasteur.uy), will collaborate to identify the central upstream triggers that drive inflammation in autoimmune

Read More
Novadip announces the implantation of the first two patients in its phase 3 pivotal trial of NVD003 in CPT

Novadip announces the implantation of the first two patients in its phase 3 pivotal trial of NVD003 in CPT

During February and March 2026, the first two patients enrolled in Novadip's pivotal phase 3 trial for the treatment of Congenital Pseudarthrosis of the Tibia (CPT) were successfully implanted with NVD003 in Belgium and the US. NVD003, an autologous bone graft created from a patient’s own adipose stem cells, is

Read More